ADMA Biologics Inc.
ADMA | NASDAQ
$9.51
+$0.40 (+4.39%)
At close: Sep 21, 2026, 4:00 PM ET
$9.51
$0 (-0.01%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 510.17M | 426.45M | 258.22M | 154.08M | 80.94M | 42.22M |
Cost of Revenue | 217.41M | 206.9M | 169.27M | 118.82M | 79.77M | 61.29M |
Gross Profit | 292.77M | 219.55M | 88.94M | 35.27M | 1.17M | -19.07M |
Operating Income | 191.44M | 138.98M | 21.63M | -39.37M | -58.37M | -64.91M |
Interest Income | 1.87M | 2.1M | 1.62M | 44.83K | 34.53K | 288.13K |
Pretax Income | 182.66M | 125.71M | -28.24M | -65.9M | -71.65M | -75.75M |
Net Income | 146.93M | 197.67M | -28.24M | -65.9M | -71.65M | -75.75M |
Selling & General & Admin | 91.58M | 74.12M | 59.02M | 52.46M | 42.9M | 35.05M |
Research & Development | 4.76M | 1.81M | 3.3M | 3.61M | 3.65M | 5.91M |
Other Expenses | 4.98M | 4.63M | 4.99M | 18.56M | 13M | 4.89M |
Operating Expenses | 101.32M | 80.57M | 67.31M | 74.63M | 59.55M | 45.84M |
Interest Expense | 7.11M | 13.93M | 25.03M | 19.28M | 13.06M | 11.99M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 318.73M | 287.47M | 236.58M | 193.45M | 139.32M | 107.13M |
Income Tax Expense | 35.73M | -71.96M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 238.3M | 233.08M | 223.98M | 197.87M | 139.58M | 86.15M |
Shares Outstanding (Diluted) | 244.9M | 243.34M | 223.98M | 197.87M | 139.58M | 86.15M |
EPS (Basic) | 0.62 | 0.85 | -0.13 | -0.43 | -0.61 | -1.02 |
EPS (Diluted) | 0.60 | 0.81 | -0.13 | -0.43 | -0.61 | -1.02 |
EBITDA | 197.86M | 147.69M | 5.12M | -39.51M | -53.1M | -59.82M |
EBIT | 189.77M | 139.64M | -3.21M | -46.63M | -58.59M | -63.76M |
Depreciation & Amortization | 8.1M | 8.05M | 8.33M | 7.11M | 5.5M | 3.94M |
Add to Watchlist
Select watchlists to add or remove ADMA